Sixth Acquisition Extends Veranex Lead in MedTech Industry Services
Veranex expands global capabilities for human-centered design, innovation, and strategy
2 min read
Jessica Casimir : Mar 24, 2025 10:22:43 PM
Most recently Ryan was the Chief Commercial Officer at Sense Biodetection, a venture-backed molecular diagnostics innovator. Prior, he was a Vice President at Edwards Lifesciences’ Critical Care business, CCO at Astute Medical, and V.P. of CareFusion’s (now BD’s) respiratory technologies business.
Veranex’s Chairman & CEO, Pat Donnelly, shared his excitement about the impactful commercial leader joining the team: “All of us here at Veranex could not be more thrilled to have Ryan Roberts join the leadership team.
– Pat Donnelly, Veranex CEO and Chairman
Roberts also shared how eager he is to begin this new journey: “Veranex’s portfolio of conceptualization to commercialization services is unparalleled in the market. I’m enthused about the opportunity we have to accelerate market readiness of meaningful, outcomes-changing technologies for our customers and the caregivers and patients they serve.”
About Veranex
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept through to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time while its integrated and comprehensive solutions unify the entire development process.
Veranex expands global capabilities for human-centered design, innovation, and strategy
Raleigh, NC, December 14, 2023—Veranex, provider of the first purpose-built, global service platform for the medtech industry, today announced that...
1 min read
The addition increases footprint and provides speed, flexibility, and depth of GLP services to North America and the EU. Veranex, the first...